BioSpace News Archive

Drug Development

Axonics® Completes Enrollment of U.S. FDA Pivotal Study for its Sacral Neuromodulation System

ARTISAN-SNM is a 120-patient, single-arm, prospective clinical study designed to demonstrate the safety and effectiveness of the Axonics r-SNM System as an aid in the treatment of urinary dysfunction in patients who have failed or could not tolerate more conservative treatments.

June 27, 2018
·
3 min read
Business

Golden Meditech Announces FY2017/2018 Annual Results

Healthcare Services Business Achieves Organic Growth and Diversification

June 27, 2018
·
19 min read
Biotech Beach

LGR6+ Cells And Defensin Peptides Deliver A New, Targeted Avenue For Treating Skin Aging

Tiny molecule reprograms our body to create young skin

June 27, 2018
·
4 min read
Business

Bionik Laboratories Reports Fiscal Year 2018 Financial Results

Strengthened the board of directors with the appointment of Andre Auberton-Herve as chairman and P. Gerald Malone and Joseph Martin as directors, bringing years of strategic, financial and management expertise

June 27, 2018
·
25 min read
Biotech Bay

AcelRx receives European Commission approval for DZUVEO™

AcelRx’s DZUVEO receives EU approval for management of acute moderate to severe pain in medically monitored settings

June 27, 2018
·
4 min read
Genetown

U.S. Department of Defense Awards $3.5 Million Grant to Platelet BioGenesis

Research award will support development of donor-independent platelets to treat battlefield and civilian casualties

June 27, 2018
·
3 min read
Business

Level Brands, Inc. Signs Deal with Boston Therapeutics

Boston Therapeutics’ patented Sugardown® diabetes supplement to be marketed under kathy Ireland® Health & Wellness brand

June 27, 2018
·
5 min read
Drug Development

The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following [Third] Review of Unblinded Data

More than 1,550 patient-years of safety data accumulated to date – a three-fold increase over total patient exposure through Phase II trials

June 27, 2018
·
3 min read
Policy

2019 Labor HHS Appropriations Bill Calls For NCI Implemention Of New Pilot Program To Improve Patient Access To Cancer Trials

Language change aims to increase access to cancer clinical trials among underrepresented and minority communities

June 27, 2018
·
2 min read
Pharm Country

Novartis announces funding for patient advocacy initiatives to support and empower metastatic breast cancer community

STEP (Solutions to Empower Patients)™ Program helps nonprofit organizations deliver innovative solutions to patient communities

June 27, 2018
·
7 min read